Ozempic, Wegovy, Zepbound, and Mounjaro are having a significant impact on human health and wellbeing. These ‘GLP-1 receptor agonists’ reduce appetite and blood glucose levels, and can lead to significant weight loss. They have been embraced by many overweight and obese people as .

What is GLP-1?

The story of GLP-1, the hormone having its moment, is tied to the events that took place at the University of Toronto in January 1922. A research group that comprised Fred Banting, Charlie Best, and James Collip, overseen by Professor John Macleod, isolated a factor from animal pancreases that they proposed, based on earlier animal studies, would reduce the hyperglycemia (high blood sugar) of diabetes.… Read the rest “A brief history of the glp-1 receptor agonists”